跳至主要内容
临床试验/NCT01910779
NCT01910779Unknown不适用

Optimization of Initial Energy for Cardioversion of Atrial Fibrillation With Biphasic Shocks (OPTIMA Trial).

Maria Vittoria Hospital2 个研究点 分布在 1 个国家目标入组 154 人开始时间: 2013年5月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
154
试验地点
2
主要终点
Electrical cardioversion success

研究概览

简要总结

Use of higher energy doses (120-150 J) may not offer additional benefits and higher success rate compared with low to moderate initial energy (100-120 J) of biphasic shock for atrial fibrillation cardioversion. In this prospective open-label randomized trial consecutive patients with AF and candidate to AF electrical cardioversion will be randomized to receive 100J or 120 J as initial dose of biphasic shock. Patients will be also randomized in each group to anterolateral or postero-anteriore placement of defibrillator electrodes.

详细描述

Open-label randomized trial to assess the efficacy of alternative initial biphasic shocks (100 versus 120 J) for cardioversion of atrial fibrillation including alternative option for electrode placement (anterolateral or postero-anterior in each group).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult (Age>18 years)
  • Candidate to Cardioversion for recent onset, persistent atrial fibrillation (>48 hours but < 12 months)
  • Informed Consent

排除标准

  • Atrial Flutter or other arrythmias

结局指标

主要结局

Electrical cardioversion success

时间窗: Day 1

次要结局

  • Electrical cardioversion success(3 months)
  • Complications rate(Day 1)

研究者

发起方
Maria Vittoria Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Massimo Imazio

MD

Maria Vittoria Hospital

研究点 (2)

Loading locations...

相似试验